Non-invasive measurement of pH

• US 7,198,756 B2
• Filed: 07/11/2002
• Issued: 04/03/2007
• Est. Priority Date: 07/11/2002
• Status: Expired due to Fees

• Current Assignee: Optical Sensors Incorporated
• Original Assignee: Optical Sensors Incorporated
• Inventors: Furlong, Steven C., Kimball, Victor E., Pierskalla, Irvin
• Primary Examiner(s): Cole; Monique T.
• Application Number:
  US10/195,004
• Publication Number:
  US 20040009606A1
• Time in Patent Office: 1,727 Days
• Field of Search: 436/163, 436/164, 422/50, 422/68.1, 422/82.05, 422/82.08, 422/82.09
• US Class Current: 422/82.08
• CPC Class Codes: A61B 5/14539 for measuring pH
• CPC Class Codes: A61B 5/1455 using optical sensors, e.g. spectral photometrical oximeters
• CPC Class Codes: G01N 21/6486 Measuring fluorescence of biological material, e.g. DNA, RNA, cells G01N21/6428 takes precedence
• CPC Class Codes: G01N 21/80 Indicating pH value

Abstract

There is a need within the medical community for non-invasive instruments to measure critical physiologic parameters at the point of care. Such a technique may be applicable to a wide variety of commonly monitored physiologic parameters during critical care patient management. The invention is directed to a method of measuring the pH of a patient'"'"'s tissue. The method includes measuring the optical signal from a specie whose fluorescence is pH sensitive, such as nicotinamide adenine dinucleotide (NADH) and also measuring the optical signal from a second biological marker, such as FAD, the fluorescence from the second marker being substantially insensitive to pH. The method includes determining the patient'"'"'s pH by using the first and second optical signals.

Claims

1. A system for measuring pH in a medium, comprising:

a light source for optically exciting the medium;

a detection unit to detect a first optical signal from a fluorescent biomolecule in the medium whose fluorescence is dependent on the pH of the medium and to detect a second optical signal from a marker in the medium whose fluorescence is substantially independent of pH of the medium wherein the detection unit includes a wavelength light separator to separate light received from the medium into the first optical signal received from the fluorescent biomolecule and the second optical signal, and also includes respective first and second photodetectors to detect the first and second optical signals; and

a controller coupled to receive detection signals from the detection unit related to the first and second optical signals, the controller configured to determine the medium pH based on the first and second optical signals.

2. A system as recited in claim 1, further comprising a patient interface couplable to the medium, the patient interface including an excitation port for directing exciting light from the light source to the medium, and at least one detection port to receive light from the medium and direct the received light to the detection unit.

3. A system as recited in claim 2, wherein the detection unit detects fluorescent light from the fluorescent biomolecule.

4. A system as recited in claim 3, wherein the detection unit detects fluorescent light from the fluorescent biomolecule in the range of about 435–

475 nm.

5. A system as recited in claim 2, wherein the detection unit detects fluorescent light from the marker.

6. A system as recited in claim 5, wherein the detection unit detects fluorescent light from the marker in the range of about 510 nm–

600 nm.

7. A system as recited in claim 2, wherein the detection unit detects an absorbance signal for light absorbed by the fluorescent biomolecule.

8. A system as recited in claim 2, wherein the detection unit detects the absorbance signal for light in the range of about 330–

390 nm.

9. A system as recited in claim 2, wherein the detection unit detects an absorbance signal for light absorbed by the marker.

10. A system as recited in claim 2, wherein the detection unit detects the absorbance signal for light in the range of about 340–

405 nm.

11. A system as recited in claim 1, wherein the detection unit detects light from the fluorescence of NADH in the range 400 nm–

500 nm.

12. A system as recited in claim 1, wherein the marker is FAD.

13. A system as recited in claim 12, wherein the detection unit detects light from the fluorescence of FAD in the range 500 nm–

600 nm.

14. A system as recited in claim 1, wherein the controller determines the pH of the medium by calculating a ratio, R=S₁/S₂, where S₁ is a signal indicative of the first optical signal and S₂ is a signal indicative of the second optical signal, and also includes calculating pH of the medium using R.

15. A system for measuring pH in a medium, comprising:

a light source for optically exciting the medium;

a detection unit to detect a first optical signal from a fluorescent biomolecule in the medium whose fluorescence is dependent on the pH of the medium and to detect a second optical signal from a marker in the medium whose fluorescence is substantially independent of pH of the medium, wherein the detection unit includes a spectrally dependent path through a spectral scanning device to a photosensor, the spectral scanning device operative in a first configuration associated with the first optical signal from the fluorescent biomolecule and a second configuration associated with the second optical signal from the marker; and

a controller coupled to receive detection signals from the detection unit related to the first and second optical signals, the controller configured to determine the medium pH based on the first and second optical signals.

16. A system as recited in claim 15, further comprising a patient interface couplable to the medium, the patient interface including an excitation port for directing exciting light from the light source to the medium, and at least one detection port to receive light from the medium and direct the received light to the detection unit.

17. A system as recited in claim 16, wherein the detection unit detects fluorescent light from the fluorescent biomolecule.

18. A system as recited in claim 17, wherein the detection unit detects fluorescent light from the fluorescent biomolecule in the range of about 435–

475 nm.

19. A system as recited in claim 16, wherein the detection unit detects fluorescent light from the marker.

20. A system as recited in claim 19, wherein the detection unit detects fluorescent light from the marker in the range of about 510 nm–

600 nm.

21. A system as recited in claim 16, wherein the detection unit detects an absorbance signal for light absorbed by the fluorescent biomolecule.

22. A system as recited in claim 16, wherein the detection unit detects the absorbance signal for light in the range of about 330–

390 nm.

23. A system as recited in claim 16, wherein the detection unit detects an absorbance signal for light absorbed by the marker.

24. A system as recited in claim 16, wherein the detection unit detects the absorbance signal for light in the range of about 340–

405 nm.

25. A system as recited in claim 15, wherein the detection unit detects light from the fluorescence of NADH in the range 400 nm–

500 nm.

26. A system as recited in claim 15, wherein the marker is FAD.

27. A system as recited in claim 26, wherein the detection unit detects light from the fluorescence of FAD in the range 500 nm–

600 nm.

28. A system as recited in claim 15, wherein the controller determines the pH of the medium by calculating a ratio, R=S₁/S₂, where S₁ is a signal indicative of the first optical signal and S₂ is a signal indicative of the second optical signal, and calculates the pH of the medium using R.